{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:54:46Z","timestamp":1761173686301,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.purol.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T16:22:10Z","timestamp":1573921330000},"page":"181-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concepts et m\u00e9thodes d\u2019\u00e9valuation en pelvi p\u00e9rin\u00e9ologie\u00a0: du score de sympt\u00f4mes aux attentes et r\u00e9sultats rapport\u00e9s par les patients (PRO)"],"prefix":"10.1016","volume":"30","author":[{"given":"N.","family":"Turmel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chesnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Le Breton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Charlanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.purol.2019.10.005_bib0175","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2019.10.005_bib0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cct.2004.09.003","article-title":"Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels","volume":"25","author":"Willke","year":"2004","journal-title":"Control Clin Trials"},{"issue":"7","key":"10.1016\/j.purol.2019.10.005_bib0185","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.1989.03430070073033","article-title":"The Medical Outcomes Study. An application of methods for monitoring the results of medical care","volume":"262","author":"Tarlov","year":"1989","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.purol.2019.10.005_bib0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1524-4733.2004.72252.x","article-title":"Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues","volume":"7","author":"Shikiar","year":"2004","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.purol.2019.10.005_bib0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"European Association of Urology. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2019.10.005_bib0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","article-title":"Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score","volume":"68","author":"Homma","year":"2006","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.purol.2019.10.005_bib0205","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1067\/mob.2001.118659","article-title":"Psychometric evaluation of 2\u00a0comprehensive condition-specific quality of life instruments for women with pelvic floor disorders","volume":"185","author":"Barber","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.purol.2019.10.005_bib0210","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/bju.14121","article-title":"Which outcome measures should be used in stress urinary incontinence trials?","volume":"121","author":"Lim","year":"2018","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.purol.2019.10.005_bib0215","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","article-title":"A new questionnaire to assess the quality of life of urinary incontinent women","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"6846","key":"10.1016\/j.purol.2019.10.005_bib0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36\u00a0health survey questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.purol.2019.10.005_bib0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000052421","article-title":"Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen","volume":"39","author":"Costa","year":"2001","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2019.10.005_bib0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","article-title":"Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q","volume":"11","author":"Coyne","year":"2002","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.purol.2019.10.005_bib0235","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mob.2003.379","article-title":"Validation of two global impression questionnaires for incontinence","volume":"189","author":"Yalcin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.purol.2019.10.005_bib0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.purol.2019.10.005_bib0245","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1524-4733.2008.00323.x","article-title":"Development and validation of the \u201cTreatment Satisfaction with Medicines Questionnaire\u201d (SATMED-Q)","volume":"11","author":"Ruiz","year":"2008","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.purol.2019.10.005_bib0250","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2019.10.005_bib0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/nau.1930140206","article-title":"Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group","volume":"14","author":"Uebersax","year":"1995","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.purol.2019.10.005_bib0260","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.urology.2007.11.100","article-title":"Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP\u00a9) questionnaire","volume":"71","author":"Haab","year":"2008","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.purol.2019.10.005_bib0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/qhc.9.4.210","article-title":"Validation of a questionnaire measuring patient satisfaction with general practitioner services","volume":"9","author":"Grogan","year":"2000","journal-title":"Qual Health Care"},{"issue":"3","key":"10.1016\/j.purol.2019.10.005_bib0270","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.20455","article-title":"Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire","volume":"27","author":"Piault","year":"2008","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 1","key":"10.1016\/j.purol.2019.10.005_bib0275","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1524-4733.2005.00069.x","article-title":"The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue-the BSW","volume":"8","author":"Pleil","year":"2005","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.purol.2019.10.005_bib0280","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/nau.20672","article-title":"Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q)","volume":"28","author":"Margolis","year":"2009","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.purol.2019.10.005_bib0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/nau.20890","article-title":"Patient satisfaction with the benefits of overactive bladder treatment: exploration of influencing factors and development of a satisfaction assessment instrument","volume":"30","author":"Zinner","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.purol.2019.10.005_bib0290","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.urology.2008.05.033","article-title":"Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder","volume":"72","author":"Colman","year":"2008","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.purol.2019.10.005_bib0295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12570-012-0100-3","article-title":"The validation of the visual analogue scale for patient satisfaction after total hip arthroplasty","volume":"3","author":"Brokelman","year":"2012","journal-title":"Eur Orthop Traumatol"},{"issue":"10","key":"10.1016\/j.purol.2019.10.005_bib0300","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/j.1464-410X.2010.09684.x","article-title":"Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder","volume":"107","author":"Cartwright","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2019.10.005_bib0305","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.eururo.2006.11.015","article-title":"Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ)","volume":"52","author":"Basra","year":"2007","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2019.10.005_bib0310","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1464-410X.2005.05345.x","article-title":"Validation of the urgency perception scale","volume":"95","author":"Cardozo","year":"2005","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.purol.2019.10.005_bib0315","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/nau.21005","article-title":"Validation of the urinary sensation scale (USS)","volume":"30","author":"Coyne","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2019.10.005_bib0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-7525-7-55","article-title":"The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms","volume":"7","author":"Black","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.purol.2019.10.005_bib0325","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF01530764","article-title":"Goal attainment scaling: A general method for evaluating comprehensive community mental health programs","volume":"4","author":"Kiresuk","year":"1968","journal-title":"Community Ment Health J"},{"issue":"8","key":"10.1016\/j.purol.2019.10.005_bib0330","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00192-011-1382-7","article-title":"Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire","volume":"22","author":"Brubaker","year":"2011","journal-title":"Int Urogynecol J"},{"issue":"4","key":"10.1016\/j.purol.2019.10.005_bib0335","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.juro.2013.10.046","article-title":"Long-term adherence to antimuscarinic therapy in everyday practice: a systematic review","volume":"191","author":"Veenboer","year":"2014","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.purol.2019.10.005_bib0170","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00345-018-2580-4","article-title":"Lower urinary tract symptoms treatment constraints assessment (LUTS-TCA): a new tool for a global evaluation of neurogenic bladder treatments","volume":"37","author":"Turmel","year":"2019","journal-title":"World J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708719306049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708719306049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:32:30Z","timestamp":1761114750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708719306049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1166708719306049"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2019.10.005","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concepts et m\u00e9thodes d\u2019\u00e9valuation en pelvi p\u00e9rin\u00e9ologie\u00a0: du score de sympt\u00f4mes aux attentes et r\u00e9sultats rapport\u00e9s par les patients (PRO)","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}